These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34254327)

  • 1. Approaches for setting occupational exposure limits in the pharmaceutical industry.
    Ahuja V; Krishnappa M
    J Appl Toxicol; 2022 Jan; 42(1):154-167. PubMed ID: 34254327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting occupational exposure limits for antimicrobial agents: A case study based on a quaternary ammonium compound-based disinfectant.
    Dotson GS; Lotter JT; Zisook RE; Gaffney SH; Maier A; Colvin J
    Toxicol Ind Health; 2020 Sep; 36(9):619-633. PubMed ID: 33241765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
    Tynkkynen S; Santonen T; Stockmann-Juvala H
    Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.
    Lovsin Barle E; Winkler GC; Glowienke S; Elhajouji A; Nunic J; Martus HJ
    Toxicol Sci; 2016 May; 151(1):2-9. PubMed ID: 27207978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An occupational exposure limit (OEL) approach to protect home healthcare workers exposed to common nebulized drugs.
    Frank E; Ishau S; Maier A; Reutman S; Reichard JF
    Regul Toxicol Pharmacol; 2019 Aug; 106():251-261. PubMed ID: 31047944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry Derived Occupational Exposure Limits: A Survey of Professionals on the Dutch System of Exposure Guidelines.
    Schenk L; Visser MJ; Palmen NGM
    Ann Work Expo Health; 2019 Nov; 63(9):1004-1012. PubMed ID: 31504142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the benchmark-dose (BMD) approach to derive occupational exposure limits (OELs) for genotoxic carcinogens: N-nitrosamines.
    Blum K; FitzGerald R; Wilks MF; Barle EL; Hopf NB
    J Appl Toxicol; 2023 Aug; 43(8):1183-1200. PubMed ID: 36840679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying nonhazardous substances in pharmaceutical manufacturing and setting default health-based exposure limits (HBELs).
    Wiesner L; Araya S; Lovsin Barle E
    J Appl Toxicol; 2022 Sep; 42(9):1443-1457. PubMed ID: 35315528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interdisciplinary framework for derivation of occupational exposure limits.
    Maurer LL; Alexander MS; Bachman AN; Grimm FA; Lewis RJ; North CM; Wojcik NC; Goyak KO
    Front Public Health; 2022; 10():1038305. PubMed ID: 36530659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational exposure limits for manufactured nanomaterials, a systematic review.
    Mihalache R; Verbeek J; Graczyk H; Murashov V; van Broekhuizen P
    Nanotoxicology; 2017 Feb; 11(1):7-19. PubMed ID: 27894206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.
    Gould J; Callis CM; Dolan DG; Stanard B; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S79-93. PubMed ID: 27233924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Landscape of Occupational Exposure Limits--Implementation of Harmonization Principles to Guide Limit Selection.
    Deveau M; Chen CP; Johanson G; Krewski D; Maier A; Niven KJ; Ripple S; Schulte PA; Silk J; Urbanus JH; Zalk DM; Niemeier RW
    J Occup Environ Hyg; 2015; 12 Suppl 1(sup1):S127-44. PubMed ID: 26099071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and regulation of occupational exposure limits in Japan.
    Takahashi K; Higashi T
    Regul Toxicol Pharmacol; 2006 Nov; 46(2):120-5. PubMed ID: 16510222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and regulation of occupational exposure limits in Korea.
    Paek D; Park DY
    Regul Toxicol Pharmacol; 2006 Nov; 46(2):126-30. PubMed ID: 16564609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation of occupational exposure limits: Differences in methods and protection levels.
    Schneider K; Dilger M; Drossard C; Ott H; Kaiser E
    J Appl Toxicol; 2022 May; 42(5):913-926. PubMed ID: 35188277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonization efforts for deriving health-based exposure limits in the pharmaceutical industry - Advancing the current science and practice.
    Weideman PA; Pecquet AM; Maier MA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S1-2. PubMed ID: 27531049
    [No Abstract]   [Full Text] [Related]  

  • 17. A scoping survey of attitudes towards occupational exposure limits and REACH derived no effect levels for workers among chemical risk managers at Swedish workplaces.
    Schenk L
    Int J Occup Med Environ Health; 2020 Sep; 33(5):611-620. PubMed ID: 32699425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive changes to occupational exposure limits in Korea.
    Jeong JY; Choi S; Kho YL; Kim PG
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):345-8. PubMed ID: 20709131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of occupational exposure limits in Japan.
    Kaneko T; Wang PY; Sato A
    Int J Occup Med Environ Health; 1998; 11(1):81-98. PubMed ID: 9637997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.
    Hayes EP; Jolly RA; Faria EC; Barle EL; Bercu JP; Molnar LR; Naumann BD; Olson MJ; Pecquet AM; Sandhu R; Shipp BK; Sussman RG; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S39-47. PubMed ID: 27267172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.